Latest Breaking News On - Paul edick - Page 1 : comparemela.com

Xeris Biopharma Holdings, Inc (NASDAQ:XERS) Q1 2024 Earnings Call Transcript

Xeris Biopharma Holdings, Inc (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesXeris careconnectionOren livnatKelly closeAllison weyGvoke hypopenLeland gershellXerisol levothyroxineJohn shannonSteven pieperPaul edickDavid amsellemRoanna ruizRohan mathurSteve pieperPiper sandler

Xeris Biopharma Holdings, Inc s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions

Key Insights The considerable ownership by retail investors in Xeris Biopharma Holdings indicates that they.

Paul edickBlackrock incXeris biopharma holdingsXeris biopharma holdingXeris biopharma holdings incXeris biopharmaXeris biopharma holdingsInstitutional investorsRetail investors

Xeris Biopharma inks exclusive worldwide license agreement with Amgen for XeriJect in thyroid eye disease

Xeris Biopharma inks exclusive worldwide license agreement with Amgen for XeriJect in thyroid eye disease
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Paul edickXeri xerijectXeris biopharma holdingsThyroid eye disease

Xeris Biopharma Holdings Shares Jump 14% on Raised 2023 Outlook

By Denny Jacob Xeris Biopharma Holdings shares jumped 14%, to $2.56, after the biopharmaceutical company raised part of its outlook for 2023. The stock has.

Denny jacobPaul edickXeris biopharma holdingsBiopharma holdingsChief executive paulArticle normalBiotechnology servicesHealthcare life sciencesFinancial performanceShare price movement disruptionsCorporate industrial newsContent typesFactiva filtersC amp ampe exclusion filterC amp ampe industry news filterShare price movement

Xeris Biopharma updates FY23 outlook; remains on track for 4Q positive cash flow

Xeris Biopharma updates FY23 outlook; remains on track for 4Q positive cash flow
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesPaul edickXeris biopharma holdings